About the Company
We do not have any company description for LENZ Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on LENZ Therapeutics, Inc.
No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod
The US FDA approval of Vizz was based on results from three randomised, double-masked, controlled Phase 3 studies.
LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ETCompany ParticipantsDan Chevallard - CFOEef Schimmelpennink ...
LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy?
Shares of LENZ Therapeutics, Inc. have increased 26.99% over the past quarter, and have gained 49.13% in the last year. On the other hand, the S&P 500 has only moved 16.04% and 12.11%, respectively.
LENZ Therapeutics to Present at Upcoming Investor Conferences ... - Nasdaq
LENZ Therapeutics, Inc., a biopharmaceutical company focusing on an aceclidine-based eye drop for improving near vision in people with presbyopia, has announced its upcoming participation in ...
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are ...
Shares of LENZ Therapeutics, Inc. LENZ rose sharply in today's pre-market trading. CORXEL and LENZ Therapeutics revealed topline data from China Phase 3 Presbyopia trial of LNZ100. LENZ ...
LENZ Therapeutics Inc. Company & People | LENZ | Barron's
LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision.
LENZ Therapeutics, Inc. (LENZ) Is Up 3.37% in One Week: What ... - Nasdaq
Over the past quarter, shares of LENZ Therapeutics, Inc. Have risen 54.15%, and are up 114.17% in the last year. On the other hand, the S&P 500 has only moved 13.08% and 38.58%, respectively.
LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript
LENZ Therapeutics, Inc. (NASDAQ: LENZ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Dan Chevallard - Chief Financial Officer Eef Schimmelpennink - President and CEO ...
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q1 2024 Earnings Call Transcript
LENZ Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by.
Similar Companies
Loading the latest forecasts...